ESALY

Eisai Co., Ltd. ESALY

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ESALY TAIPY IPSEF IHHHF UHS LPCUF ODTC KKPCF AIHLF PEXXF
6M 53.27 % -6.23 % 0.00 % 21.85 % 29.25 % 1.12 % -83.87 % -15.81 % 42.86 % 0.00 %
YTD -7.29 % -7.47 % -9.76 % 21.85 % 26.39 % 1.12 % -83.87 % -11.69 % 42.86 % 0.00 %
1Y 23.02 % 47.76 % -9.76 % 21.85 % 25.37 % 1.12 % -83.33 % -11.69 % 42.86 % 0.00 %
3Y -16.39 % -1.69 % 27.83 % 8.21 % 60.75 % 190 200.01 % -78.00 % -15.54 % 11.46 % 0.00 %
5Y 18.15 % -26.49 % 10.42 % 26.09 % 66.32 % -83.45 % -99.13 % -35.73 % -18.79 % 0.00 %
10Y 37.91 % -27.46 % 75.18 % -8.23 % 90.26 % -83.45 % -98.80 % -35.73 % -18.79 % 0.00 %
From the beginning 211.44 % -27.46 % 251.55 % -17.61 % 17 780.31 % -82.54 % -98.80 % -35.73 % -30.69 % 0.00 %

Dividend

Eisai Co., Ltd.

Taisho Pharmaceutical Holdings Co., Ltd.

Ipsen S.A.

IHH Healthcare Berhad

Universal Health Services, Inc.

Lee's Pharmaceutical Holdings Limited

Kaken Pharmaceutical Co., Ltd.

Adcock Ingram Holdings Limited

PT Tempo Scan Pacific Tbk